Mosaic ImmunoEngineering (CPMV) Other Non Operating Income (2011 - 2025)
Mosaic ImmunoEngineering (CPMV) posted quarterly Other Non Operating Income of $14000.0 for Q1 2025, down 33.33% quarter-over-quarter from $21000.0 in Q4 2024.
Mosaic ImmunoEngineering (CPMV) Other Non Operating Income (2011 - 2025) Analysis & Trends
Mosaic ImmunoEngineering's Other Non Operating Income history runs 13 years deep, the most recent figure standing at $14000.0 for Q1 2025.
- In Q1 2025, Other Non Operating Income changed N/A year-over-year to $14000.0; the TTM figure through Dec 2025 stood at $14000.0 (down 66.67% YoY), while the FY2025 annual figure was $14000.0, down 66.67% from the prior year.
- Other Non Operating Income for Q1 2025 stood at $14000.0, down from $21000.0 in the prior quarter.
- The five-year high for Other Non Operating Income was $56700.0 in Q3 2022, with the low at -$20800.0 in Q2 2021.
- The 5-year median for Other Non Operating Income is $13400.0 (2023), against an average of $13950.0.
- The sharpest annual moves came in 2022 and 2023: Other Non Operating Income soared 103.85% in 2022, then soared 4137.5% in 2023.
- Mosaic ImmunoEngineering's Other Non Operating Income stood at -$20800.0 in 2021, then soared by 98.08% to -$400.0 in 2022, then surged by 8575.0% to $33900.0 in 2023, then sank by 38.05% to $21000.0 in 2024, then plunged by 33.33% to $14000.0 in 2025.
- Business Quant data shows CPMV's Other Non Operating Income at $14000.0 in Q1 2025, $21000.0 in Q4 2024, and $21000.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Mosaic ImmunoEngineering | 3.68 Mn | 3.68 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 14,000.00 |
| Dec 31, 2024 | 21,000.00 |
| Sep 30, 2024 | 21,000.00 |
| Jun 30, 2023 | 33,900.00 |
| Mar 31, 2023 | 12,800.00 |
| Dec 31, 2022 | -400.00 |
| Sep 30, 2022 | 56,700.00 |
| Jun 30, 2022 | 800.00 |
| Mar 31, 2022 | 500.00 |
| Jun 30, 2021 | -20,800.00 |
| Nov 30, 2018 | -8,197.00 |
| Aug 31, 2018 | -7,837.00 |
| May 31, 2018 | 773.00 |
| Feb 28, 2018 | 3,094.00 |
| Nov 30, 2017 | -96,877.00 |
| Aug 31, 2017 | -6,942.00 |
| May 31, 2017 | -1.17 Mn |
| Feb 28, 2017 | -28,058.00 |
| Nov 30, 2016 | 1.25 Mn |
| Aug 31, 2016 | -50,896.00 |